Related Experiment Video
Updated: Jun 4, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Interferon Point Alteration in Hospitalized Patients with and Without COVID-19
Mehran Rezvani Habibabadi1, Mahmoud Saghaei1, Ali Ghahramani2
1Department of Anesthesiology, Isfahan University of Medical Sciences, Isfahan, Iran.
Introduction:
Integrating traditional Chinese medicine with Western medicine has been extensively studied in managing respiratory disease. Therefore, in this study, we aimed to examine interferon point alteration (IPA) and its association with disease severity in patients with COVID-19.
Methods:
This cross-sectional study was conducted on patients hospitalized due to COVID-19 with lung involvement. The control group consisted of patients hospitalized with a diagnosis other than COVID-19. The prevalence of IPA was compared between patients with and without COVID-19. Clinical and laboratory findings were compared in patients with and without IPA.
Results:
A total of 126 participants, with a mean (SD) age of 57.2 (16.4) years, were included in this study. 54.8% of participants were men. There was a significant difference between patients with and without COVID-19 regarding the frequency of IPA (p = 0.045). No significant differences were observed between variables in patients with and without IPA (p ≥ 0.05). The only variable that could significantly predict the IPA in COVID-19 patients was the severity score of lung involvement in HRCT (OR: 5.32, 95% CI: 1.08-26.05, p = 0.039). IPA showed a sensitivity and specificity of 80.9% and 34.9% in identifying COVID-19 patients, respectively.
Conclusion:
Our study found a significant association between IPAs and the severity of lung involvement in hospitalized COVID-19 patients and a significant association of COVID-19 with IPAs.
More Related Videos
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Viral Mutations
Controls in Experiments
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: